$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
News
News
Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
Which manufacturer of lenvatinib/lenvatinib is better?
2026-02-01 22:25:32
Check Details
Is taking one pill of lenvatinib/lenvatinib a day effective?
2026-02-01 22:25:32
Check Details
Lenvatinib/Lenvatinib Capsules: Existing form, mechanism of action and medication guidance
2026-02-01 22:25:32
Check Details
Lenvatinib/lenvatinib: Characteristics and applications of third-generation targeted antitumor drugs
2026-02-01 22:25:32
Check Details
Lenvatinib/lenvatinib medication cycle: Can I stop for 7 days after taking it for 21 days?
2026-02-01 22:25:32
Check Details
Overview of the latest selling price and efficacy of lorlatinib in 2024
2026-02-01 22:25:32
Check Details
Analysis of the latest market price of lorlatinib in 2023
2026-02-01 22:25:32
Check Details
Discussion on the price of lorlatinib after it is included in medical insurance
2026-02-01 22:25:32
Check Details
Lorlatinib (lorlatinib) medical insurance price analysis in 2024
2026-02-01 22:25:32
Check Details
Analysis of the latest quotation and treatment effect of Lenvatinib in 2024
2026-02-01 22:25:32
Check Details
Lenvatinib (lenvatinib) market price trend in 2024
2026-02-01 22:25:32
Check Details
Domestic price analysis of lenvatinib after it is included in medical insurance
2026-02-01 22:25:32
Check Details
1
2
...
717
718
719
720
721
722
723
...
10211
10212
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Loargys(Pegzilarginase-nbln) Complete Medication Guide: Pre-Treatment Assessment, Monitoring and Home Administration
2
Plerixafor Complete Side Effect Guide: Adverse Reaction Classification and Professional Management
3
Selpercatinib Complete Medication Guide: Indications, Dosage and Safety Information for RET Inhibitor
4
Complete Guide to Dosage and Dose Adjustment of Entrectinib
5
Comprehensive Analysis of Bleeding Risk with Tepotinib in MET-Mutated Non-Small Cell Lung Cancer
6
Lomustine vs Temozolomide: Comprehensive Comparison of Efficacy and Safety in Glioma Treatment
7
Sopyrronium Bromide (Sofdra) for Hyperhidrosis: Uses, Mechanism and Facial Application Risks
8
Optimal Dosing Time and Medication Principles of Vigabatrin (Sabril)
9
Tepotinib and Osimertinib: Current Status and Clinical Positioning of Combination Therapy in Non-Small Cell Lung Cancer
10
Tumor Shrinkage Effect and Core Therapeutic Value of Pazopanib
11
Cabotegravir Sodium: Pioneering Long-Acting Solution for HIV Treatment and Prevention
12
Tabrecta (Capmatinib): A Targeted Therapy for METex14-Mutated NSCLC